Evidence map›Paper›PMID 28749339›Full record

ArticleeLife2017

PTEN controls glandular morphogenesis through a juxtamembrane β-Arrestin1/ARHGAP21 scaffolding complex.

Arman Javadi, Ravi K Deevi, Emma Evergren, Elodie Blondel-Tepaz, George S Baillie, Mark Gh Scott, Frederick C Campbell

Open access · goldAbstract read
In one paragraph

Article in eLife, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Fixing the GAP: The role of RhoGAPs in cancer.European journal of cell biology · 2022
    Review
  5. Article
  6. PTEN as a Guardian of the Genome: Pathways and Targets.Cold Spring Harbor perspectives in medicine · 2020
    Review
  7. Posttranslational Regulation and Conformational Plasticity of PTEN.Cold Spring Harbor perspectives in medicine · 2020
    Review
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Arman Javadi *Centre for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, United Kingdom.
Ravi K Deevi *Centre for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, United Kingdom.
Emma EvergrenCentre for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, United Kingdom.
Elodie Blondel-TepazInserm, U1016, Institut Cochin, Paris, France.
George S BaillieInstitute of Cardiovascular and Medical Science, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland.
Mark Gh ScottInserm, U1016, Institut Cochin, Paris, France.ORCID http://orcid.org/0000-0002-1557-1856
Frederick C CampbellCentre for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, United Kingdom.ORCID http://orcid.org/0000-0002-0363-9964
Queen's University Belfast · GBDélégation Paris 5 · FRUniversity of Glasgow · GB

Funding

Cancer Research UK 15342Cancer Research UK C9136/A15342Medical Research Council MC_PC_15039Medical Research Council MR/J007412/1
6 · The paper itself

Abstract

PTEN controls three-dimensional (3D) glandular morphogenesis by coupling juxtamembrane signaling to mitotic spindle machinery. While molecular mechanisms remain unclear, PTEN interacts through its C2 membrane-binding domain with the scaffold protein β-Arrestin1. Because β-Arrestin1 binds and suppresses the Cdc42 GTPase-activating protein ARHGAP21, we hypothesize that PTEN controls Cdc42 -dependent morphogenic processes through a β-Arrestin1-ARHGAP21 complex. Here, we show that PTEN knockdown (KD) impairs β-Arrestin1 membrane localization, β-Arrestin1-ARHGAP21 interactions, Cdc42 activation, mitotic spindle orientation and 3D glandular morphogenesis. Effects of PTEN deficiency were phenocopied by β-Arrestin1 KD or inhibition of β-Arrestin1-ARHGAP21 interactions. Conversely, silencing of ARHGAP21 enhanced Cdc42 activation and rescued aberrant morphogenic processes of PTEN-deficient cultures. Expression of the PTEN C2 domain mimicked effects of full-length PTEN but a membrane-binding defective mutant of the C2 domain abrogated these properties. Our results show that PTEN controls multicellular assembly through a membrane-associated regulatory protein complex composed of β-Arrestin1, ARHGAP21 and Cdc42.

Indexed as

Animalsbeta-Arrestin 1Binding SitesCaco-2 Cellscdc42 GTP-Binding ProteinCell MembraneGene Expression RegulationGTPase-Activating ProteinsHCT116 CellsHEK293 CellsHumansMiceMice, Inbred C57BLOrganoidsProtein BindingPTEN PhosphohydrolaseARHGAP21 protein, humanARRB1 protein, humanbeta-Arrestin 1cdc42 GTP-Binding ProteinCDC42 protein, humanGTPase-Activating ProteinsPTEN PhosphohydrolasePTEN protein, humanRNA, Small InterferingARHGAP21Arrestincancer biologyCdc42 proteincell biologyhumanMorphogenesisPTEN

Identifiers

PMID28749339
PMCPMC5576923
OpenAlexW2736997579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.